Based in Smiths Falls, Ontario, founded by Bruce Linton and Chuck Rifici in 2014. Canopy Growth advances the world’s perception of cannabis by focusing on research, product development innovative production capabilities. Canopy Growth operates ten licensed cannabis production sites with over 2.7 million square feet of production capacity, including over 500,000 square feet of GMP certified production space. The Company has operations in 11 countries across five continents.

The Company is proudly dedicated to educating healthcare practitioners, conducting robust clinical research, and furthering the public’s understanding of cannabis, and through its partly owned subsidiary, Canopy Health Innovations, has devoted millions of dollars toward cutting edge, commercializable research and IP development.

Canopy Growth has established partnerships with leading sector names including cannabis icon Snoop Dogg, breeding legends DNA Genetics and Green House seeds, and Fortune 500 alcohol leader Constellation Brands, to name but a few.


Headquartered in Edmonton, Alberta, with funded capacity in excess of 570,000 kg per year and sales and operations in 14 countries across five continents, Aurora is one of the world’s largest and leading cannabis companies.

Aurora is vertically integrated and horizontally diversified across every key segment of the value chain, from facility engineering and design to cannabis breeding and genetics research, cannabis and hemp production, derivatives, high value-add product development, home cultivation, wholesale and retail distribution.

Each of Aurora’s facilities is built to meet European Union (EU) GMP standards, and its first production facility, its recently acquired MedReleaf Markham facility and its wholly owned European medical cannabis distributor Pedanios have achieved this level of certification

Wayland Group (formerly MARICANN (CSE: MARI)

Wayland Group (formerly Maricann) is a vertically integrated producer and distributor of marijuana for medical purposes. The company was founded in 2013 and is based in Burlington, Ont., Canada, and Munich, Germany, with production facilities in Langton, Ont., where it operates a medicinal cannabis cultivation, extraction, formulation and distribution business under federal licence from the government of Canada.

The company also has production operations in Dresden, Saxony, Germany, and Regensdorf, Switzerland. Wayland Group is currently undertaking an expansion of its cultivation and support facilities in Canada in a 942,000-square-foot (87,515 square and will continue to pursue new opportunities in Europe.


The Green Organic Dutchman Holdings grows high-quality, organic cannabis with sustainable, all-natural principles. The company’s products are laboratory tested to ensure patients have access to a standardized, safe and consistent product.

Also known as “TGOD”, the Ontario-based company is on-track to become the world’s largest grower of pharmaceutical-grade, premium-quality organic cannabis.

This focus on organic output extends from dried flower (cannabis buds) to a diversity of lucrative downstream products, such as organic oils, which are ideally suited to a diversity of delivery methods, including the use of vape pens and ingestible extractions.

The company is also on-track to become one of the three largest cannabis growers in Canada with over 1.6 million square feet of growing capacity, translating into 195,000 kilograms of projected annual output at full capacity. To date, TGOD has raised $315 million.


HEXO Corp. creates and distributes innovative, easy-to-use and easy-to-understand products to serve the Canadian cannabis market. One of the country’s lowest-cost producers, HEXO is rapidly increasing its production capacity in the lead up to the adult-use cannabis market.

The Company currently operates with 310,000 sq. ft. of production capacity with construction on another 1,000,000 square feet expansion set to be complete by year end. HEXO will serve the adult-use market under the HEXO brand, while continuing to serve its medical cannabis clients through the well-known Hydropothecary brand.

Aphria is a leading global cannabis company driven by an unrelenting commitment to its people, product quality and innovation. Headquartered in Leamington, Ontario — the greenhouse capital of Canada — Aphria has been setting the standard for the low-cost production of safe, clean and pure pharmaceutical-grade cannabis at scale, grown in the most natural conditions possible.

Focusing on untapped opportunities and backed by the latest technologies, Aphria is committed to bringing breakthrough innovation to the global cannabis market. The company’s portfolio of brands is grounded in expertly researched consumer insights designed to meet the needs of every consumer segment.